Or, our tax dollars at work! Last week, the FDA approved a new drug for treatment-resistant depression (TRD). The nasal spray version of the drug ketamine, called Spravato (esketamine), is a newly-approved, fast-acting drug, available only with a doctor’s prescription, that could help millions. Did you know that a wide range of nonhuman animal research … Continue reading The animal research behind the new nasal spray depression treatment